Federal law prohibits Medicare from covering drugs solely for weight loss, meaning GLP-1s are only reimbursed under Part D for other approved indications, like type 2 diabetes, cardiovascular risk reduction, MASH, or sleep apnea
Semaglutide and Tirzepatide mimics the natural hormone GLP-1 (glucagon-like peptide-1), which plays a key role in controlling appetite, regulating blood sugar, and supporting healthy metabolism
"Ozempic (semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products"
It became one of the most widely used compounds in compounding pharmacy practice before the 2023 restrictions, prescribed for musculoskeletal healing, gut inflammation, tendon repair, and recovery from soft-tissue injuries